SEOUL, REPUBLIC OF KOREA – The Federation of Asian Pharmaceutical Associations (FAPA) proudly announced the addition of the Mongolian Association of United Pharmaceutical Organizations (MAUPO) to its esteemed community of pharmaceutical leaders. The decision, finalized last year during the Closed Council Meeting on October 24, 2023, at the Taipei International Convention Center (TICC), signifies FAPA’s commitment to fostering global collaboration within the pharmaceutical industry.

At the grand opening ceremony of the 30th FAPA Congress, a moment of significant recognition unfolded as MAUPO received an official welcome into the FAPA family. Dr. Yolanda Robles, President of FAPA, presented Dr. Enkhjargal Dorjval, the President of MAUPO, with the certificate of membership.

The association was established in 1996 October 23rd to protect the legitimate interests and activities of Mongolian pharmaceutical organizations and pharmaceutical specialists. It is a non-profit organization whose purpose is to regulate, support and serve its members.

MAUPO’s considerations are: 

1. Licensing of the drug manufacturers and importers
2. Standardizations of pharmacy practice, pharmaceutical premises and drug laboratories
3. Pharmacopoeia committee at the MOH
4. Participate in planned and unplanned inspection of pharmaceutical companies with the Inspection agency in Mongolia as a technical expert  (community pharmacies, hospital pharmacies and pharmaceutical manufacturers)
5. Participate to stop illegal activities pharmaceutical companies with the Inspection agency in Mongolia according to market compliance which is based on inspecting reports (not involved in the judgement)
6. Participate to tender selection activities as a technical expert who have special license A3
7. Participate in the evaluation of  GMP implementing process of pharmaceutical manufacturers with the MOH as a professional expert 
8. Organize planned and unplanned training (GMP, GLP, GDP, GCP, GSP .. so on), according to requested by members (community pharmacies, hospital pharmacies and pharmaceutical manufacturers)
9. A branch consulting agency of professional